LMU Researchers Combine Machine Learning and Molecular Dynamics to Discover Novel RNA Delivery Materials. While experimental screening of polymer libraries is time-consuming and costly, purely ...

LipidVerse 2025, a landmark one-day conference dedicated to exploring cutting-edge advancements in lipid-based technologies ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

A hard-right Christian legal advocacy organization is moving shop from Laurel to Helena, with the Montana Family Foundation ...

Common anti-vaccine talking points were on display as the CDC’s immunization advisers repealed a hepatitis B birth vaccine recommendation and scrutinized the childhood schedule.

Harmony Biosciences Holdings, Inc. , today announced that it will highlight new open-label extension data from the company's investigation of EPX-100 (clemizole hydrochloride) in the ongoing Phase 3 ...

A groundbreaking clinical trial is underway in the UK for LungVax, an experimental vaccine designed to prevent lung cancer. This innovative approach trains the immune system to identify and eliminate ...

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...

This report provides useful evidence that EABR mRNA is at least as effective as standard S mRNA vaccines for the SARS-CoV-2 booster vaccine. Although the methodology and the experimental approaches ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...